Vimarsana
Biggest News Aggregation in the World

Marlene Chan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marlene Chan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marlene Chan Today - Breaking & Trending Today

6 things to do this May long weekend in York Region - Vimarsana News

6 things to do this May long weekend in York Region

Enjoy these long weekend activities in York Region: Vaughan’s ribfest, a talk on the history of the Chinese community in York Region, a tour of the Richmond Hill David Dunlap Observatory, classes on building confidence to deal with difficult people, storytime for children, and a blood donation event in Aurora.

Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies - Vimarsana News

Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies

Palazestrant in combination with the CDK 4/6 inhibitors, ribociclib and palbociclib, demonstrated no significant drug-drug interaction, no dose-limiting toxicities and a tolerability profile...

Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS) - Vimarsana News

Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)

Presentations detailing initial Phase 1b clinical data for palazestrant in combination with ribociclib, a Poster Spotlight Session on Phase 2 clinical data for palazestrant in combination with...

OP-1250 Plus Palbociclib Demonstrates Activity, Safety in HR+/HER2– Metastatic Breast Cancer - Vimarsana News

OP-1250 Plus Palbociclib Demonstrates Activity, Safety in HR+/HER2– Metastatic Breast Cancer

The combination of OP-1250 and palbociclib produced a tolerable safety profile and elicited tumor responses and disease stabilization in patients with hormone receptor–positive, HER2-negative metastatic breast cancer.

Fighting for change in Chinatown - Vimarsana News

Fighting for change in Chinatown

Chinatowns across Canada are under threat. In Edmonton’s Chinatown, six months after two men were killed, people are fighting to save a district long troubled by crime and disorder.

Source: cbc.ca